article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

Changes in regulations can have ripple effects throughout the industry, impacting supply chains, investment strategies, and consumer access to medical cannabis products. Effective supply chain management encompasses inventory management, transportation logistics, and compliance with regulatory requirements.

article thumbnail

Press Release: ACS Laboratory Launches Comprehensive Hemp Compliance Testing Panel

Cannabis Law Report

Hemp supply chain companies need qualified third-party laboratories that meticulously follow nuanced laws to ensure their products are permissible across the country. The diverse regulations mean multi-state hemp operators need reliable support to remain compliant.

article thumbnail

American CBD Pioneer GenCanna Acquires London-Based CBD Provider, CBD Capital

Cannabis Law Report

The injection of both financial and human capital, combined with GenCanna’s formidable CBD ingredient extraction and refinement sciences, and its sterling compliance track record, will now greatly facilitate the expansion and completion of several key channel strategies and market growth initiatives currently within the CBD Capital pipeline.”.

CBD 102
article thumbnail

Press Release: HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

Cannabis Law Report

Additionally, it validates the Company’s supply chain business model of providing psilocybin for clinical use and research, adding to previously announced supply partnerships this year with Mycrodose Therapeutics , Mycotopia Therapies , Cube Psytech , Allied Health , ATMA Journey Centers , Revive Therapeutics and HealthTech Connex.

article thumbnail

Press Release: HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

Cannabis Law Report

comes on the heels of HAVN Life’s recent announcement of the import of naturally derived psilocybin into Canada by their supply partner, Nectar Health Sciences Laboratory Division Inc., The supply of psilocybin to Mycrodose therapeutics will be in compliance with all applicable rules and regulations of the U.S.